Annual Publications

May 06, 2026

Dee and Jimmy Haslam Make $12.5 Million Transformational Investment in Blood Cancer Research and Treatments at University Hospitals

Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center CLEVELAND, Ohio, U.S. and OXFORD, U.K. – University Hospitals (UH) has received $12.5 million in transformational...